Novavax, a developer of recombinant nanoparticle vaccines and adjuvants, has named Jody Lichaa as Vice President, Quality Assurance.
Lichaa joined Novavax as Executive Director, Quality Assurance in October 2011. She is responsible for providing strategy, oversight, and direction of the company’s quality assurance.
Prior to joining Novavax, she was Senior Director, Quality at PharmAthene from 2005 until 2011, where she managed global QA/QC activities. Her prior experience includes quality assurance positions of increasing responsibility in a number of companies including Baxter, Shire and BioReliance.
